CA1105925A - Pentapeptide compositions and methods - Google Patents

Pentapeptide compositions and methods

Info

Publication number
CA1105925A
CA1105925A CA296,490A CA296490A CA1105925A CA 1105925 A CA1105925 A CA 1105925A CA 296490 A CA296490 A CA 296490A CA 1105925 A CA1105925 A CA 1105925A
Authority
CA
Canada
Prior art keywords
val
tyr
polypeptide
asp
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA296,490A
Other languages
English (en)
French (fr)
Inventor
Gideon Goldstein
David H. Schlesinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Application granted granted Critical
Publication of CA1105925A publication Critical patent/CA1105925A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA296,490A 1977-11-15 1978-02-08 Pentapeptide compositions and methods Expired CA1105925A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85177777A 1977-11-15 1977-11-15
US851,777 1977-11-15

Publications (1)

Publication Number Publication Date
CA1105925A true CA1105925A (en) 1981-07-28

Family

ID=25311654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA296,490A Expired CA1105925A (en) 1977-11-15 1978-02-08 Pentapeptide compositions and methods

Country Status (7)

Country Link
JP (2) JPS5476543A (enrdf_load_stackoverflow)
BE (1) BE864121A (enrdf_load_stackoverflow)
CA (1) CA1105925A (enrdf_load_stackoverflow)
CH (1) CH639941A5 (enrdf_load_stackoverflow)
DE (1) DE2804566C2 (enrdf_load_stackoverflow)
FR (1) FR2408580A1 (enrdf_load_stackoverflow)
SE (1) SE446867B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
ZA802170B (en) * 1979-04-12 1981-11-25 Ortho Pharma Corp Peptides having thymopoietin-like activity
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
BE864121A (fr) 1978-08-21
CH639941A5 (en) 1983-12-15
JPS6118560B2 (enrdf_load_stackoverflow) 1986-05-13
JPS6150998A (ja) 1986-03-13
DE2804566C2 (de) 1986-01-16
FR2408580A1 (fr) 1979-06-08
FR2408580B1 (enrdf_load_stackoverflow) 1983-01-07
DE2804566A1 (de) 1979-05-17
JPH0137399B2 (enrdf_load_stackoverflow) 1989-08-07
SE446867B (sv) 1986-10-13
JPS5476543A (en) 1979-06-19
SE7801030L (sv) 1979-05-16

Similar Documents

Publication Publication Date Title
US4190646A (en) Polypeptide compositions and methods
AU625598B2 (en) Peptides having t cell helper activity
US4261886A (en) Peptides having thymopoietin-like activity
KR940001007B1 (ko) 펩타이드의 제조방법
US4002740A (en) Tridecapeptide compositions and methods
US4215112A (en) Tripeptides and methods
EP0016612B1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
US4190647A (en) Polypeptides and methods
CA1105925A (en) Pentapeptide compositions and methods
US4397842A (en) Peptides having thymopoietin-like activity
CA1157466A (en) Peptides having thymopoietin-like activity
CA1120031A (en) Tetrapeptides and methods
CA1105923A (en) Pentapeptides and methods
US4258152A (en) Pentapeptide modified resin
US4258151A (en) Pentapeptide modified resin
GB1565032A (en) Polypeptide compositions and methods for their manufacture
US4232008A (en) Tetrapeptides and methods
GB1585736A (en) Polypeptides and methods for their production

Legal Events

Date Code Title Description
MKEX Expiry